These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3876508

  • 1. The clinical syndrome of striatal dopamine deficiency: parkinsonism induced by MPTP.
    Eldridge R, Rocca WA.
    N Engl J Med; 1985 Oct 31; 313(18):1159-60. PubMed ID: 3876508
    [No Abstract] [Full Text] [Related]

  • 2. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ.
    N Engl J Med; 1985 May 30; 312(22):1418-21. PubMed ID: 2581135
    [Abstract] [Full Text] [Related]

  • 3. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 May 30; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 4. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K, Ogawa N, Sora YH.
    Res Commun Chem Pathol Pharmacol; 1988 Jan 30; 59(1):121-8. PubMed ID: 3258432
    [Abstract] [Full Text] [Related]

  • 5. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr 30; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 6. Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
    Kopin IJ.
    Adv Neurol; 1987 Apr 30; 45():137-44. PubMed ID: 3493621
    [No Abstract] [Full Text] [Related]

  • 7. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul 30; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 8. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW.
    N Engl J Med; 1992 Nov 26; 327(22):1556-63. PubMed ID: 1435882
    [Abstract] [Full Text] [Related]

  • 9. MPTP and parkinsonism.
    Bianchine JR, McGhee B.
    Ration Drug Ther; 1985 Feb 26; 19(2):5-7. PubMed ID: 3876575
    [No Abstract] [Full Text] [Related]

  • 10. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
    Averkin RG, Korshunov VA, Shchegolevskiĭ NV, Mats VN, Markevich VA, Grigor'ian GA, Bazian AS.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2010 Feb 26; 60(1):109-19. PubMed ID: 20352690
    [Abstract] [Full Text] [Related]

  • 11. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA, Jarvis MF, Wagner GC.
    Res Commun Chem Pathol Pharmacol; 1985 Jul 26; 49(1):145-8. PubMed ID: 3875884
    [Abstract] [Full Text] [Related]

  • 12. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL, Hashim A, Lajtha A, Sershen H.
    J Neurosci Res; 1989 Jul 26; 23(3):326-9. PubMed ID: 2504936
    [Abstract] [Full Text] [Related]

  • 13. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW.
    Fortschr Neurol Psychiatr; 1989 Apr 26; 57(4):142-8. PubMed ID: 2656447
    [Abstract] [Full Text] [Related]

  • 14. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys.
    Guttman M, Yong VW, Kim SU, Calne DB, Martin WR, Adam MJ, Ruth TJ.
    Synapse; 1988 Apr 26; 2(5):469-73. PubMed ID: 3263709
    [Abstract] [Full Text] [Related]

  • 15. Interference of 3-O-methyldopa with L-dopa treatment for MPTP-induced parkinsonism in mice.
    Fujitake J, Kuno S, Mizuta E.
    Adv Neurol; 1990 Apr 26; 53():225-9. PubMed ID: 2239462
    [No Abstract] [Full Text] [Related]

  • 16. The neurochemical and clinical effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in small animals.
    Donnan GA, Kaczmarczyk SJ, Solopotias T, Rowe P, Kalnins RM, Vajda FJ, Mendelsohn FA.
    Clin Exp Neurol; 1986 Apr 26; 22():155-64. PubMed ID: 3495376
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of adenosine increase in the striatum in common marmoset parkinsonism induced by MPTP.
    Nomoto M, Shimizu T, Iwata S, Kaseda S, Fukuda T.
    Adv Neurol; 1999 Apr 26; 80():125-8. PubMed ID: 10410711
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK, Mehta AK, Aley KO, Shukla VK.
    Methods Find Exp Clin Pharmacol; 1986 Aug 26; 8(8):485-9. PubMed ID: 3489146
    [Abstract] [Full Text] [Related]

  • 20. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
    Przedborski S, Jackson-Lewis V, Popilskis S, Kostic V, Levivier M, Fahn S, Cadet JL.
    Neurochirurgie; 1991 Aug 26; 37(6):377-82. PubMed ID: 1780015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.